Y Zhao, Y Chen, M Jin, J Wang - Theranostics, 2021 - ncbi.nlm.nih.gov
Epigenetic regulation involves a range of sophisticated processes which contribute to heritable alterations in gene expression without altering DNA sequence. Regulatory events …
CY Sun, D Cao, BB Du, CW Chen… - International Journal of …, 2022 - ncbi.nlm.nih.gov
RNA can be modified by over 170 types of distinct chemical modifications, and the most abundant internal modification of mRNA in eukaryotes is N6-methyladenosine (m 6 A). The …
X Cao, Q Geng, D Fan, Q Wang, X Wang, M Zhang… - Molecular cancer, 2023 - Springer
Abstract N6-methyladenosine (m6A) methylation is the most universal internal modification in eukaryotic mRNA. With elaborate functions executed by m6A writers, erasers, and …
F Dai, Y Wu, Y Lu, C An, X Zheng, L Dai, Y Guo… - … Therapy-Nucleic Acids, 2020 - cell.com
N6-methyladenosine (m 6 A) is the most common RNA modification and has an important role in normal development and tumorigenesis. The abnormal expression of m 6 A …
J Cui, J Tian, W Wang, T He, X Li, C Gu… - Cancer …, 2021 - Wiley Online Library
To explore the effect of insulin‐like growth factor 2 mRNA‐binding protein 2 (IGF2BP2) on colorectal cancer (CRC) by recognizing the m6A modification of YAP mRNA thus activating …
QN Wu, XJ Luo, J Liu, YX Lu, Y Wang, J Qi, ZX Liu… - Cancer research, 2021 - AACR
Long noncoding RNAs (lncRNA) are involved in tumorigenesis and drug resistance. However, the roles and underlying mechanisms of lncRNAs in colorectal cancer are still …
C Dahlem, A Abuhaliema, SM Kessler… - ACS chemical …, 2022 - ACS Publications
The RNA-binding protein IGF2BP2/IMP2/VICKZ2/p62 is overexpressed in several tumor entities, promotes tumorigenesis and tumor progression, and has been suggested to worsen …
N Dai - Trends in Endocrinology & Metabolism, 2020 - cell.com
The human insulin-like growth factor 2 (IGF2) mRNA binding protein family (IMPs/IGF2BPs) is involved in a spectrum of biological processes, including development, tumorigenesis …
X Hou, C Du, L Lu, S Yuan, M Zhan, P You… - World Journal of Surgical …, 2022 - Springer
Background As reported, preclinical animal models differ greatly from the human body. The evaluation model may be the colossal obstacle for scientific research and anticancer drug …